Clinical Trials on Febrile Neutropenia

Total 499 results

52 North Health Ltd

Not yet recruiting

Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. (NeutroUSE)

Neutropenia | Neutropenia, Febrile | Neutropenic Sepsis (Disorder)
Shanghai Jiao Tong University School of Medicine

Recruiting

Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever

Safety Issues

China
National Taiwan University Hospital

Completed

Assessment of sTREM-1 as a Diagnostic Marker in Patients With Neutropenic Fever

Neutropenic Fever
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Recruiting

Fast-track Blood Test for Suspected Fever by Deficiency of a Kind of White Blood Cells As Main Defense Against Infection (FRANCiS-NF)

Neutropenic Fever

Hong Kong
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Solid Tumors | Malignant Hemopathy | Chemotherapy-induced Febrile Neutropenia (FN)

France
Institut Rafael

Active, not recruiting

Patient Preference Between a Prefilled Syringe or a Prefilled Pen Device for Administration of Pegfilgrastim (PELGRAZ)

Patient Satisfaction | Patient Preference | Febrile Neutropenia, Drug-Induced

France
TTY Biopharm

Completed

A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

Neutropenia, Febrile

Taiwan
University Hospital, Brest

Completed

Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit (REANEUF)

Neutropenia, Febrile

France
Kuopio University Hospital

Completed

Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients

Sepsis

Finland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm

United States
Dongkook Pharmaceutical Co., Ltd.

Completed

Pharmacokinetics and Safety of AmBisome and DKF-5122

Invasive Fungal Infections | Neutropenic Fever

Korea, Republic of
Amgen

Completed

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Chemotherapy-induced Febrile Neutropenia

France, Italy, Poland, Canada, Spain, Austria, Germany, Greece, Romania, Australia, Ireland
University Hospital, Lille
Ministry of Health, France

Recruiting

DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule (DISCERN-FN7)

Neutropenia, Febrile

France
Hospital Infantil de Mexico Federico Gomez
Hospital Juarez de Mexico; Instituto Nacional de Pediatria

Completed

Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia

Chemotherapy-Induced Febrile Neutropenia
All India Institute of Medical Sciences, New Delhi

Terminated

Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study (DALFEN)

Pediatric Cancer | Neutropenia, Febrile

India
Kjeld Schmiegelow

Recruiting

Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer

Pediatric Cancer | Neutropenia, Febrile

Denmark
Pfizer

Completed

Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia

Non-Interventional Study

Germany
Prince of Songkla University
Merck Sharp & Dohme LLC

Completed

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Patients With Febrile Neutropenia

Thailand
University of Mississippi Medical Center

Unknown

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

Pediatric Cancer | Chemotherapy-Induced Febrile Neutropenia | Chemotherapy-induced Neutropenia | Granulocyte Colony-Stimulating Factor

United States
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Recruiting

Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia (SAFE)

Neutropenia, Febrile

Belgium
University Hospital, Lille
Ministry of Health, France; Ligue contre le cancer, France

Completed

Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy

Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy

France
Cliniques universitaires Saint-Luc- Université...

Terminated

Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia (CALIF)

Febrile Neutropenia, Drug-Induced

Belgium
Hamad Medical Corporation
Merck Sharp & Dohme LLC

Withdrawn

CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients (CEF-10)

Hematologic Cancer | Neutropenia, Febrile

Qatar
University Hospital, Basel, Switzerland

Completed

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Febrile Neutropenia (FN)

Switzerland
Dr. Yishai Ofran

Unknown

Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

Critically Ill Patients | Neutropenic Fever Patients | Patients With Hip Fractures

Israel
Rigshospitalet, Denmark
Danish Cancer Society; Lundbeck Foundation; Børnecancerfonden

Completed

Host RNA Signature in Children With Cancer and Infection

Childhood Cancer | Infection | Neutropenia, Febrile

Denmark
Indonesia University

Completed

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Leukemia | Pediatric Cancer | Neutropenia, Febrile | Antibiotic Reaction

Indonesia
Amgen

Completed

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

Chemotherapy-induced Febrile Neutropenia

Belgium, Poland, Germany, Czechia, Austria, France, Greece, Romania, Bulgaria
The Christie NHS Foundation Trust
University of Manchester; Isansys Lifecare LTD

Unknown

Remote Monitoring of Patients at Risk of Sepsis (REACT)

Sepsis | Cancer | Neutropenia, Febrile

United Kingdom
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Cinnagen

Completed

Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN

Chemotherapy-induced Neutropenia
Stanford University
Theranos, Inc.

Completed

Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias

Leukemia, Myeloid | Leukemia, Lymphocytic

United States
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk

China
Lei Li

Unknown

G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients

Gynecologic Cancer | Febrile Neutropenia | Chemotherapy-induced Neutropenia | Myelosuppression Adult

China
Hospital Universitari de Bellvitge
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Recruiting

Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients (BEATLE)

Febrile Neutropenia

Spain
Poitiers University Hospital

Withdrawn

Amoxicillin-clavulanate Alone or in Combination With Ciprofloxacin in Low-Risk Febrile Neutropenic Adult Patients: A Prospective, Double-blind, Randomized, Non-Inferiority Multicenter, Phase III Clinical Trial. (ACACIA)

Febrile Neutropenia
Centre Hospitalier Universitaire de Nīmes

Terminated

Evaluation of Intestinal Bacterial and Fungal Translocation and Intestinal Microbiota in Febrile Neutropenic Patients in Pediatric Onco-hematology (TRANSNEUTROFEB)

Febrile Neutropenia

France
Rabin Medical Center

Withdrawn

Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia

Febrile Neutropenia

Israel
University Health Network, Toronto

Not yet recruiting

Short Antibiotic Treatment in High Risk Febrile Neutropenia

Febrile Neutropenia
Fundación para la Investigación Biosanitaria del...
Instituto de Salud Carlos III; Instituto de Investigación Marqués de Valdecilla

Recruiting

A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)

Febrile Neutropenia

Spain
Center for Supporting Hematology-Oncology Trials
Bayer

Completed

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Febrile Neutropenia

Japan
Federal University of Minas Gerais

Completed

Procalcitonin Protocol to Shorten the Antibiotic Therapy in Febrile Neutropenia

Febrile Neutropenia

Brazil
Brigham and Women's Hospital
Astellas Pharma US, Inc.

Completed

Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia

Febrile Neutropenia

United States
Centre Hospitalier Universitaire Vaudois
Unisanté Centre universitaire de médecine générale et santé publique; FORCE...

Not yet recruiting

Adjustment of Antibiotic Dosage in Pediatric Oncology Patients With Febrile Neutropenia and Augmented Renal Clearance (DAR-ARC)

Febrile Neutropenia

Switzerland
Gary E. Stein, Pharm.D.

Completed

Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients

Febrile Neutropenia

United States
Universidad Nacional Autonoma de Mexico
Hospital Infantil de Mexico Federico Gomez; Centro de Investigación y Estudios...

Unknown

Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia

Febrile Neutropenia

Mexico
Fundación Pública Andaluza para la gestión de la...

Completed

Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia (HOWLONG)

Febrile Neutropenia

Spain
Pfizer

Completed

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

Febrile Neutropenia

Turkey
Tel-Aviv Sourasky Medical Center

Unknown

Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia (RR)

Fever | Febrile Neutropenia

Israel
Ottawa Hospital Research Institute

Completed

A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study) (React-G)

Early Stage Breast Cancer

Canada

Clinical Trials on Febrile Neutropenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations